P.S. Free & New ACNS dumps are available on Google Drive shared by Pass4Leader: https://drive.google.com/open?id=17Qk3xbGzWla_dABH-r5mKdj9GF9VEs_j
In order to gain the ACNS certification quickly, people have bought a lot of ACNS study materials, but they also find that these materials don't suitable for them and also cannot help them. If you also don't find the suitable ACNS test guide, we are willing to recommend that you should use our ACNS Study Materials. Because our products will help you solve the problem, it will never let you down if you decide to purchase and practice our ACNS latest question. And our ACNS exam questions have a high pass rate of 99% to 100%.
| Section | Objectives |
|---|---|
| Topic 1: Clinical Judgment and Advanced Practice Nursing | - Comprehensive health assessment and differential diagnosis
|
| Topic 2: Patient and Family Outcomes Management | - Care coordination and chronic disease management
|
| Topic 3: Evidence-Based Practice and Research | - Translation of research into clinical practice
|
| Topic 4: Professional Role Development | - Advanced practice nursing roles and ethics
|
| Topic 5: Systems Leadership and Quality Improvement | - Healthcare systems improvement
|
As you all know that practicing with the wrong preparation material will waste your valuable money and many precious study hours. So you need to choose the most proper and verified preparation material with caution. Preparation material for the ACNS exam questions from Pass4Leader helps to break down the most difficult concepts into easy-to-understand examples. Also, you will find that all the included questions are based on the last and updated ACNS Exam Dumps version. We are sure that using Pass4Leader's Nursing Exam Questions preparation material will support you in passing the ACNS exam with confidence.
NEW QUESTION # 160
Which of the following is NOT an appropriate way to incorporate complementary therapies into a patient's plan of care?
Answer: C
Explanation:
In healthcare settings, respecting and accommodating a patient's beliefs, preferences, and cultural backgrounds is crucial to providing holistic and patient-centered care. Complementary therapies, which can include a range of practices outside of mainstream medicine, such as Reiki, prayer, meditation, and the use of healing stones, are increasingly recognized for their potential to contribute positively to patient outcomes. However, the integration of these therapies into a patient's care plan must be handled with sensitivity and respect for the patient's autonomy and specific wishes.
One fundamental principle in this context is the requirement for informed consent. This means that any complementary therapy should only be performed after a patient has been fully informed about the nature of the therapy and has explicitly agreed to it. This is particularly important when the therapies have religious or spiritual connotations that may not align with the patient's own beliefs or preferences.
For example, praying Christian prayers over a patient who is Jewish - and who has not given consent - is inappropriate and disrespectful. This action disregards the patient's own religious beliefs and potentially violates their rights to receive care that respects their cultural and personal identity. Such an act can cause distress and could be seen as an imposition of the caregiver's beliefs on the patient, which is ethically unacceptable in a professional healthcare setting.
In contrast, allowing the practice of complementary therapies that align with the patient's expressed beliefs and with their consent is generally acceptable. For instance, if a patient requests the presence of a Reiki healer or asks that a small altar of healing stones be constructed by their bedside, and these requests do not interfere with medical care or the rights of others, accommodating such requests can be a valuable part of patient-centered care. Similarly, praying with a patient who has requested such an interaction respects and supports their spiritual needs.
In summary, when incorporating complementary therapies into a patient's care plan, healthcare providers must ensure that these interventions are consented to by the patient and are congruent with the patient's beliefs and preferences. The primary goal should always be to support the health and well-being of the patient in a manner that respects their individuality and autonomy.
NEW QUESTION # 161
Which statement is true regarding the Varicella vaccine?
Answer: A
Explanation:
The correct statement regarding the Varicella vaccine is that women who do not have immunity should receive the first dose upon completion or termination of pregnancy and before discharge from the health-care facility.
Varicella, also known as chickenpox, is a highly contagious disease caused by the Varicella-zoster virus. The Varicella vaccine is effective in preventing this disease or in reducing the severity of the symptoms if the disease does occur. The vaccine is typically given in two doses, with the first dose administered at 12 months of age and the second dose at 4-6 years of age.
The recommendation for administering the Varicella vaccine to postpartum women or women who have just terminated a pregnancy who do not have immunity is based on the need to protect these women from contracting Varicella, which can be more severe in adults than in children. It is also a preventive measure to avoid transmitting the virus to newborns who are particularly vulnerable to severe complications from the disease.
Vaccination before discharge from the healthcare facility ensures that women receive timely protection against the virus, particularly if they are at risk of exposure or have been exposed during pregnancy. It's important to note that the vaccine should not be given during pregnancy, as it contains live, attenuated virus particles.
The statement about the vaccination schedule for children (at 2, 4, 6, and 15 months) is incorrect. The Varicella vaccine is not scheduled to be administered at these ages. Instead, as previously mentioned, the correct ages are 12 months and 4-6 years.
Regarding the effectiveness of the vaccine, it is known to provide strong immunity against the Varicella virus. Most individuals who receive the vaccine will gain permanent immunity, significantly reducing the risk of developing chickenpox or, if the disease does occur, experiencing milder symptoms. This protection is crucial not just for the individual's health but also for public health as it helps in controlling the spread of the virus.
In summary, among the statements provided, the one about the need for non-immune women to receive the Varicella vaccine post-pregnancy is correct and highlights an important aspect of disease prevention and control in vulnerable populations.
NEW QUESTION # 162
When discussing Human Immunodeficiency virus (HIV) testing with a patient, the CNS knows:
Answer: D
Explanation:
The correct answer is: "The screening ELISA test (enzyme-linked immunosorbent assay) detects antibodies and is 99% sensitive and specific." It is important to clarify why this statement is correct and to address the misconceptions around HIV risk and testing. Firstly, the ELISA test is a widely used initial screening tool for detecting antibodies to HIV. Antibodies are proteins that the body produces in response to an infection. In the case of HIV, these antibodies generally develop within a few weeks to months after infection. The sensitivity and specificity of the ELISA test being around 99% means that the test is highly effective at correctly identifying those who have and do not have HIV. A test with 99% sensitivity will correctly identify 99% of people with the disease and miss 1%, while a test with 99% specificity will correctly rule out the disease in 99% of people who do not have the disease, mistakenly identifying 1% as positive.
Addressing the first statement, it is a misconception that only sexually active homosexual men are at risk for HIV. HIV can affect anyone, regardless of sexual orientation, age, race, or any other factor. It is transmitted through contact with infected bodily fluids such as blood, semen, vaginal fluids, and breast milk. This can happen through unprotected sexual activities with an infected person, sharing needles for drug use, receiving unsafe injections, transfusions, and from mother to child during childbirth or breastfeeding.
Furthermore, the statement about rechecking the ELISA test highlights the concept of the "window period." The window period is the time immediately after infection during which antibodies to HIV are not yet produced in high enough quantities to be detectable by the test. Therefore, if exposure to HIV is suspected, a follow-up test is recommended after the window period, typically around six months, to confirm the initial result. This protocol helps in capturing cases that might have been missed if tested too early after exposure.
Lastly, it is crucial to recognize broader risk factors beyond sexual orientation. Individuals with multiple sexual partners, those who engage in IV drug use, people with a history of sexually transmitted diseases (STDs), and those who were recipients of blood products between 1975 and 1985 (before widespread screening of the blood supply for HIV began) are also at increased risk. Understanding these factors can help in better targeting education, prevention, and testing efforts to those most at risk.
In summary, the CNS (Clinical Nurse Specialist) must be equipped with accurate and comprehensive knowledge about HIV transmission, testing, and the populations at risk. This ensures appropriate guidance and management of patients concerning HIV testing and prevention strategies.
NEW QUESTION # 163
You are discussing sexual activity with a homosexual male patient. The Adult Clinical Nurse Specialist knows that the greatest risk of transmitting HIV occurs during:
Answer: A
Explanation:
When discussing the greatest risk of transmitting HIV, particularly in a clinical setting with a homosexual male patient, it is crucial to understand the implications of viral load. The viral load refers to the quantity of HIV RNA in the blood. A higher viral load indicates that the virus is more plentiful in the bloodstream, thereby increasing the likelihood of transmission during sexual activities.
The risk of HIV transmission is intimately linked to the viral load of the infected individual. The primary reason why a high viral load represents the greatest risk for HIV transmission is that the virus is more present and active, making it easier to be transmitted to a sexual partner. This condition often occurs before significant immune response developments, such as the production of detectable antibodies or during acute HIV infection, which is the initial stage following the entry of the virus into the body.
During the acute phase of HIV infection, typically within a few weeks after the virus has been contracted, the individual might experience flu-like symptoms. This phase is characterized by a sharp increase in viral replication, leading to a very high viral load. Although this phase is transient, the high concentration of the virus in the blood makes it a period of very high risk for transmission.
It is a common misconception that once the body starts producing antibodies against HIV (seroconversion), the risk of transmission decreases substantially. While it's true that some level of immune response can help control the virus, the viral load can still be significantly high, particularly if the individual is not undergoing antiretroviral therapy. Thus, even at the time antibodies become detectable, if the viral load remains high, the risk of transmission persists.
In contrast, during the late phase of HIV infection, also known as the AIDS stage, while other health complications become more pronounced, the viral load might not necessarily be as high as during the acute phase or before effective treatment is administered. However, it is essential to note that without treatment, the virus can still maintain a sufficient presence to pose a transmission risk.
In summary, the greatest risk of transmitting HIV is when a high viral load exists in the blood. This is often before diagnosis and effective treatment, and particularly during the acute phase of infection. It underscores the importance of early testing and intervention to manage the viral load, thereby reducing the risk of HIV transmission to others. Awareness and education about these dynamics are crucial in clinical settings to ensure both patient and public health safety.
NEW QUESTION # 164
In terms of atrophic vaginitis, the CNS knows that all of the following are true except:
Answer: B
Explanation:
Atrophic vaginitis, also known as vaginal atrophy, primarily occurs in the genital tracts of menopausal women. This condition is associated with decreased estrogen levels, which is typical during menopause. Estrogen is crucial for maintaining the thickness and elasticity of the vaginal walls. As estrogen levels decline, the vaginal tissues become thinner, less elastic, and more susceptible to inflammation, leading to symptoms of atrophic vaginitis.
Contrary to the incorrect statement that atrophic vaginitis occurs because of an excess in estrogen, the condition actually results from a deficiency of this hormone. During menopause, the ovaries gradually produce less estrogen, leading to changes in the urogenital tract that can cause discomfort. Symptoms commonly associated with atrophic vaginitis include vaginal dryness, itching, burning, and dyspareunia (painful intercourse).
Treatment for atrophic vaginitis often involves the administration of topical estrogens. This approach helps replenish estrogen levels directly in the vaginal area, which can alleviate symptoms by restoring the health and function of the vaginal tissues. Topical estrogens are generally considered safe and effective for treating atrophic vaginitis, especially compared to systemic hormone replacement therapy, which has broader effects on the body.
In summary, the statement that atrophic vaginitis occurs because of an excess in estrogen is incorrect. The condition is actually due to a lack of estrogen, which is a key hormone for maintaining the health of vaginal tissues. Treatment typically involves the use of topical estrogens to mitigate symptoms and improve the quality of life for affected women.
NEW QUESTION # 165
......
If you purchasing the ACNS study materials designed by many experts and professors from our company, we can promise that our online workers are going to serve you day and night during your learning period. If you have any questions about our study materials, you can send an email to us, and then the online workers from our company will help you solve your problem in the shortest time. So do not hesitate to buy our ACNS Study Materials.
ACNS Exam Torrent: https://www.pass4leader.com/Nursing/ACNS-exam.html
P.S. Free & New ACNS dumps are available on Google Drive shared by Pass4Leader: https://drive.google.com/open?id=17Qk3xbGzWla_dABH-r5mKdj9GF9VEs_j